$ATXI 3 SEC Filings

Filed On	Filing
03 Jan 2025	Form 3: Fortress Biotech, Inc., 10% owner Holds 294,800 shares of COMMON STOCK, PAR VALUE $0.0001
28 Nov 2023	Form 3: Davidow Robert L, 10% owner Holds 945,000 shares of Common Stock
03 Aug 2022	Form 3: MacLean Alexandra, Chief Executive Officer No securities owned
25 May 2022	Form 3: Jin David, Int. PEO, Int. PFO, and COO No securities owned
17 May 2022	Form 3: Charles Faith L., Director No securities owned
21 Dec 2021	Form 3: Oltmans Curtis Gale, Director No securities owned
31 Dec 2019	Form 3: InvaGen Pharmaceuticals, Inc., 10% owner Holds 5,833,333 shares of Common Stock, par value $0.0001 per share
01 Aug 2019	Form 3: Ingram Elizabeth Garrett, Director No securities owned
30 Apr 2019	Form 3: Moore Thomas Gregory, Director No securities owned
15 Feb 2019	Form 3: Gogtay Jaideep Ashok, Director No securities owned
15 Feb 2019	Form 3: Saxena Nishant, Director No securities owned
11 Sep 2017	Form 3: Kranzler Jay D, Director Holds 50,000 shares of Common Stock (Restricted)
06 Sep 2017	Form 3: Reines Scott, Interim Chief Medical Officer Holds 35,000 shares of Common Stock
23 Aug 2017	Form 3: Fortress Biotech, Inc., 10% owner Holds 3,316,259 shares of Common Stock
22 Aug 2017	Form 3: Vazzano Joseph Walter, VP Finance & Corp. Controller Holds 30,000 shares of Common Stock (Restricted)
18 Aug 2017	Form 3: Herskowitz Neil, Director Holds 50,000 shares of Common Stock (Restricted)
18 Aug 2017	Form 3: Weiss Michael S, Director Holds 10,000 shares of Common Stock (Restricted)
18 Aug 2017	Form 3: Lu Lucy, Director Holds 548,333 shares of Common Stock (Restricted)
18 Aug 2017	Form 3: Rosenwald Lindsay A Md, Director Holds 10,000 shares of Common Stock (Restricted)
18 Aug 2017	Form 3: Paley Jeffrey, Director Holds 50,000 shares of Common Stock (Restricted)

Comments